Lenskart IPO Day 2 GMP Live: Strong ₹7,278 Cr Offer Sees Big Retail Buzz and Promising 13.9% Listing Gains. If you’re following India’s most anticipated IPOs, the Lenskart IPO Day 2 GMP Live update is essential. With a massive ₹7,278 crore IPO and a ₹56 grey market premium, Lenskart Solutions Ltd is quickly becoming one of the most talked-about listings of 2025.
The eyewear company’s IPO, priced between ₹382 and ₹402 per share, has drawn significant attention from both local and international investors. The anchor book shows strong demand, and the subscription numbers reflect this excitement. Lenskart’s IPO momentum indicates strong market confidence in its future growth and profits.
Lenskart IPO Overview: A High-Value Offering Backed by Strong Demand
The Lenskart IPO, worth ₹7,278 crore, opened for subscription on October 31, 2025, and will close on November 4, 2025. The price band is set at ₹382 to ₹402 per share, allowing retail investors to bid for a minimum of 37 shares, which means an investment of ₹14,874 at the upper price point.
The issue includes both Offer-for-Sale (OFS) by existing shareholders and new shares, with early investors like SoftBank Vision Fund and Kedaara Capital expected to make significant exits.
Day 2 Subscription Status: Retail Investors Lead the Way
According to BSE data (November 3, 2025, 1:14 PM), the Lenskart IPO continued to attract solid retail interest:
Qualified Institutional Buyers (QIBs) – 1.63x
Non-Institutional Investors (NIIs) – 1.45x
Retail Individual Investors (RIIs) – 2.92x
Employee Reserved Portion – 2.34x
Total Subscription – 1.82x
Earlier in the morning, the IPO had an overall subscription of 1.60x, showing consistent interest throughout the trading day. This demand, particularly from retail investors, reflects strong trust in the Lenskart brand and its market leadership in India’s eyewear sector.
Lenskart IPO GMP Today: Stable at ₹56 with 13.93% Upside Potential
As of November 3, 2025 (11:30 AM), the Lenskart IPO Grey Market Premium (GMP) was at ₹56, suggesting an expected listing price of ₹458 per share (based on the ₹402 upper price point). This means a potential listing gain of 13.93%, which is a solid advantage for short-term investors.
While the GMP has dropped slightly from earlier highs of ₹85, it remains strong, especially given the large issue size. Analysts believe this stability shows lasting investor confidence rather than short-term speculation.
Anchor Investors & Institutional Interest: Strong Backing from Global Giants
Before opening to the public, Lenskart’s anchor book experienced huge demand worth ₹50,000 crore, an impressive 15x oversubscription. Notable participants included SBI Mutual Fund, Sequoia Capital, Dragoneer Investment Group, Coatue Management, and other prominent domestic and global investors.
This extraordinary institutional participation highlights confidence in Lenskart’s profitability, scalability, and multi-channel business model, which is a unique mix in the consumer-tech IPO space.
Key Strengths: Why Investors Are Excited About Lenskart
Centralized Supply Chain & AI Efficiency: Lenskart’s fully automated, AI-driven supply chain ensures cost efficiency, quicker deliveries, and excellent quality control.
In-house Manufacturing & Innovation: The company’s in-house engineering allows it to launch new designs quickly while maintaining consistent product quality.
Direct-to-Consumer Advantage: By cutting out middlemen, Lenskart offers competitive pricing and an outstanding customer experience.
Global & Domestic Expansion: With over 2,000 stores and exports to various international markets, the brand is poised for global growth.
Risks to Watch Before Investing
Even with the positives, investors should be aware of some risks mentioned in Lenskart’s Red Herring Prospectus (RHP):
China Dependence: Some raw materials and frames come from China through its joint venture, Baofeng Framekart Technology Limited.
Legal Proceedings: Ongoing regulatory and legal issues could impact the company’s operations if the outcomes are not favorable.
Medical Advancements: The growing popularity of LASIK and SMILE surgeries might decrease the long-term demand for corrective eyewear.
Brokerage View: ‘Subscribe for Long Term’
SBI Securities rates the IPO as ‘Subscribe for Long Term.’ The brokerage points to Lenskart’s leadership in an underdeveloped eyewear market, strong brand value, and profit recovery as key strengths. While short-term listing gains might be modest, the long-term growth potential looks very positive.
Final Verdict: Promising Listing and Solid Long-Term Story
The Lenskart IPO has all the signs of a successful listing: strong retail demand, credible anchor participation, and stable GMP momentum. With India’s eyewear market expected to grow at a 13% CAGR through FY2030, Lenskart’s leadership position makes it an attractive investment.
For those looking for short-term gains, the ₹56 GMP suggests a favorable outlook. For long-term investors, Lenskart’s technology-driven business model and expanding global presence present a growth story worth watching.
Note: All information and images used in this content are sourced from Google. They are used here for informational and illustrative purposes only.
Frequently Asked Questions (FAQs) on Lenskart IPO Day 2 GMP
1. What is the price band of the Lenskart IPO Day 2 GMP update?
The Lenskart IPO Day 2 GMP highlights that the price band is set between ₹382 and ₹402 per share. This range reflects a balanced valuation, supported by the company’s strong financials, brand leadership, and investor confidence.
2. What is the size of the Lenskart IPO Day 2 GMP offer, and what does it include?
The Lenskart IPO Day 2 GMP corresponds to a ₹7,278 crore public offer, comprising both fresh issue and Offer-for-Sale (OFS) components. Existing investors like SoftBank Vision Fund and Kedaara Capital are among the major sellers in this issue.
3. How much is the Lenskart IPO Day 2 GMP today?
As of November 3, 2025 (11:30 AM), the Lenskart IPO Day 2 GMP stands at ₹56 per share. This premium suggests an estimated listing price of ₹458 per share, indicating a potential 13.93% listing gain for early investors based on the upper price band of ₹402.
4. What does the Lenskart IPO Day 2 GMP trend indicate about investor sentiment?
The rising Lenskart IPO Day 2 GMP shows strong investor optimism and growing market confidence in the company’s long-term potential. Even though the GMP slightly dropped from ₹85 earlier, the sustained premium reflects solid retail and institutional participation.
5. How has the Lenskart IPO Day 2 GMP affected subscription figures?
The healthy Lenskart IPO Day 2 GMP has influenced investor sentiment positively, leading to robust subscription numbers. As per BSE data (November 3, 2025, 1:14 PM), the IPO was subscribed 1.82 times overall, with the retail segment leading at 2.92 times.
6. Who are the major investors in the Lenskart IPO Day 2 GMP anchor book?
Before the public issue opened, the Lenskart IPO Day 2 GMP was boosted by strong anchor investor demand worth ₹50,000 crore, oversubscribed 15 times. Major names include SBI Mutual Fund, Sequoia Capital, Dragoneer Investment Group, and Coatue Management, reflecting global investor confidence.
7. What are the key strengths supporting the Lenskart IPO Day 2 GMP performance?
The Lenskart IPO Day 2 GMP performance is supported by several strong fundamentals:
- AI-driven supply chain efficiency for faster, cost-effective delivery.
- In-house manufacturing and innovation, ensuring design control and quality.
- Direct-to-consumer model, reducing costs and enhancing customer reach.
- Expanding global presence, with over 2,000 retail outlets worldwide.
8. Are there any risks highlighted in the Lenskart IPO Day 2 GMP analysis?
Yes, despite the strong market buzz, the Lenskart IPO Day 2 GMP review notes a few risks:
- China’s dependence on certain raw materials.
- Pending legal proceedings that could affect operations.
- Medical innovations like LASIK and SMILE surgeries may impact future eyewear demand.
9. What is the brokerage recommendation based on the Lenskart IPO Day 2 GMP?
As per SBI Securities, the Lenskart IPO Day 2 GMP supports a “Subscribe for Long Term” recommendation. The brokerage cites Lenskart’s market leadership, profit growth, and expansion potential as key reasons for its positive rating.
10. What is the final takeaway from the Lenskart IPO Day 2 GMP analysis?
The Lenskart IPO Day 2 GMP showcases a stable premium of ₹56, strong retail participation, and exceptional anchor investor interest. These indicators suggest a promising listing and reinforce confidence in Lenskart’s long-term growth story within India’s booming eyewear market.
Conclusion:
The Lenskart IPO Day 2 GMP continues to reflect positive market momentum, backed by powerful investor demand and strong fundamentals. Whether for short-term listing gains or long-term portfolio growth, the IPO remains one of the most compelling opportunities in 2025’s primary market landscape.
Leave a Reply